Multiple Myeloma

  • A061202: A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib Vs. Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Relapsing on Lenalidomide as Part of First Line Therapy and Proteasome Inhibitor-Based Therapy
  • For more information, contact Mia Johnson, RN, BSN at 360-788-8240